Literature DB >> 4853810

Proceedings: Effect of fenfluramine and norfenfluramine on glucose uptake by the isolated rat diaphragm.

M J Kirby, P Turner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4853810      PMCID: PMC1776665     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  A controlled investigation of the "glycolyptic" action of fenfluramine.

Authors:  J S Garrow; E A Belton; A Daniels
Journal:  Lancet       Date:  1972-09-16       Impact factor: 79.321

2.  Effects of metformin on glucose uptake by isolated diaphragm from normal and diabetic rats.

Authors:  K N Frayn; P I Adnitt
Journal:  Biochem Pharmacol       Date:  1972-12-01       Impact factor: 5.858

3.  Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration.

Authors:  D B Campbell; P Turner
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

  3 in total
  5 in total

1.  Dose related effect of fenfluramine and norfenfluramine on glucose uptake into human isolated skeletal muscle.

Authors:  M J Kirby
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

2.  Studies with flutiorex, a new anorectic drug, on glucose uptake into human isolated skeletal muscle.

Authors:  M J Kirby; H Carageorgiou-Markomihalakis; P Turner
Journal:  Br J Clin Pharmacol       Date:  1975-12       Impact factor: 4.335

3.  Effect of some receptor antagonists on fenfluramine-induced glucose uptake into the isolated rat hemidiaphragm [proceedings].

Authors:  M J Kirby; P Turner
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

4.  Ciclazindol and mazindol on glucose uptake into human isolated skeletal muscle: no interaction of mazindol with methysergide.

Authors:  M J Kirby; P Turner
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

Review 5.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.